RxDoctor Payments DataLook up a doctor →

Kelsey Kingsborough, APRN

Psychiatric/Mental Health · Mexico, MONPI 1851942619

Payments from drug & device makers

$18,410in general payments, 2019–2025

Across 1,093 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Otsuka America Pharmaceutical, Inc.$2K
  • Alkermes, Inc.$2K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
  • Neurocrine Biosciences, Inc.$2K
  • Axsome Therapeutics, Inc.$1K
  • plus $7K from 30 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$18,410 in reported general payments places this provider in the 95th percentile of 565 psychiatric/mental health providers in Missouri.

See all psychiatric/mental health providers in Missouri

Medicare billing

Part B allowed, 2024
$18,424
Medicare patients
103
Services billed
252

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatric/mental health in Mexico

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →